Al-Ghad and Al-Dawa announce the registration of Al-Sebil, Jordan's first locally produced pneumococcal vaccine
The Jordan Food and Drug Administration announced the registration of the first locally produced pneumococcal vaccine. It was developed through a contract with the Chinese company Walvax, for the benefit of Tadbik Pharmaceuticals. The vaccine is called TQ-PCV VAX 13-valent Pneumococcal Polysaccharide Conjugate Vaccine, with a dose of 0.5 ml. Its purpose is to protect individuals from infectious diseases caused by 13 different types of pneumococci.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)